NFKB1 and thyroid cancer: In thyroid cancer, some scholars have shown that the NF-κB pathway [50], PI3K/AKT signaling pathway [51], and Wnt/β-catenin pathway [52] may partially explain the unfavorable prognosis in the high expression cohort of AHNAK2.